SLC2A10 and lung carcinoma: In this study, we used the public databases Oncomine, PrognoScan, Kaplan‒Meier Plotter, TIMER and GEPIA and IFC (immunofluorescence) of lung cancer specimens to further investigate the potential prognostic value and immunological roles of SLC2A10 expression in tumors.